Literature DB >> 1935094

Preparation of monoclonal antibody to V antigen from Yersinia pestis.

K Sato1, R Nakajima, F Hara, T Une, Y Osada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1935094

Source DB:  PubMed          Journal:  Contrib Microbiol Immunol        ISSN: 0301-3081


× No keyword cloud information.
  12 in total

1.  Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system.

Authors:  Leonard R Allmond; Timur J Karaca; Vinh N Nguyen; Thong Nguyen; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

2.  Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.

Authors:  Debaditya Bhattacharya; Joan Mecsas; Linden T Hu
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

3.  Enhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion.

Authors:  Addie Embry; Xiangzhi Meng; Angelene Cantwell; Peter H Dube; Yan Xiang
Journal:  Vaccine       Date:  2011-06-12       Impact factor: 3.641

4.  Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.

Authors:  G W Anderson; S E Leary; E D Williamson; R W Titball; S L Welkos; P L Worsham; A M Friedlander
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopes.

Authors:  J K Pullen; G W Anderson; S L Welkos; A M Friedlander
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  The ADP-ribosylating toxin, AexT, from Aeromonas salmonicida subsp. salmonicida is translocated via a type III secretion pathway.

Authors:  Sarah E Burr; Katja Stuber; Joachim Frey
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

7.  Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide.

Authors:  V L Motin; R Nakajima; G B Smirnov; R R Brubaker
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

8.  Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.

Authors:  R Nakajima; R R Brubaker
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

9.  Major stable peptides of Yersinia pestis synthesized during the low-calcium response.

Authors:  R J Mehigh; R R Braubaker
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

Review 10.  Immune defense against pneumonic plague.

Authors:  Stephen T Smiley
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.